GE Healthcare has identified radiopharmaceuticals as a growth driver for the company and Japan as a key market.

NMP's product range includes GE HealthCare radiopharmaceuticals, which are essential for imaging in cardiology, oncology, and ...

GE HealthCare will acquire the remaining 50% stake in Nihon Medi-Physics, enabling it to fully own the Japanese ...

The Chicago-based medical device and technology giant plans to purchase the remaining 50% stake in Nihon Medi-Physics.

GE HealthCare (GEHC) has agreed to acquire the remaining 50% stake in Nihon Medi-Physics ((NMP)) from Sumitomo Chemical. Read ...

GE HealthCare has owned half of Nihon Medi-Physics since 2004, when former parent company General Electric obtained the stake ...

GE HealthCare Technologies Inc. (GEHC) announced its agreement to acquire the remaining 50% stake in Nihon Medi-Physics Co., Ltd or ...

GE HealthCare (GEHC) has agreed to acquire full ownership of Nihon Medi-Physics, by purchasing from Sumitomo Chemical the 50% stake it does not ...

GE HealthCare (Nasdaq: GEHC) has agreed to acquire full ownership of Nihon Medi-Physics Co., Ltd (NMP), by purchasing f ...

Physics, maker of diagnostic radiopharmaceuticals and molecular imaging agents. | GE HealthCare plans to take full control of ...

GE HealthCare to buy remaining 50% stake in Japanese radiopharmaceutical company, Nihon Medi-Physics from Sumitomo Chemical: Chalfont St Giles, UK Monday, December 2, 2024, 14:00 ...

Morphing I, a global leader in AI-based infrastructure solutions founded in 2021, is redefining industry standards by ...